Linezolid

利奈唑胺

Report date: 2026/05/26 20:00:28
NME

Base Information

Drug NameLinezolid
Drug Alias Name利奈唑烷linezolidlinezolidum雷奈佐利利奈唑酮 +[16] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Oxazolidinone antibioticsSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of Action50S ribosomal subunit inhibitors
Targets50S ribosomal subunit
Therapy Area/IndicationsHospital-acquired pneumoniaComplicated Skin and Soft Tissue InfectionsEnterococcus faecium infections +[27] 
Global Approved IndicationsHospital-acquired pneumoniaComplicated Skin and Soft Tissue InfectionsEnterococcus faecium infections +[13] 
Approved Indications in ChinaComplicated Skin and Soft Tissue InfectionsUncomplicated skin and skin structure infectionsPneumonia +[6] 
Original Approved Country/TerritoryUnited States
Original Approved Date2000/04/18
Country/TerritoryUnited StatesSlovakiaSingapore +[16] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of California San FranciscoPfizer IncUniversity Of Southern California +[6] 
Inactive CompaniesUniversity of Texas Southwestern Medical CenterCubist Pharmaceuticals LlcPrince Of Songkla University +[4] 
Active IndicationsHospital-acquired pneumoniaComplicated Skin and Soft Tissue InfectionsEnterococcus faecium infections +[13] 
Inactive IndicationsBurnsDiabetic FootOptic Nerve Diseases +[14] 

Other Information

ATC CodeJ01XX08
Related LinksWikipediaDrugBankKEGG